Back to Results
First PageMeta Content
Food and Drug Administration / Pharmacology / Pharmaceutical industry / Clinical research / National Institutes of Health / ClinicalTrials.gov / New Drug Application / FDA Fast Track Development Program / Clinical trial / Medicine / Health / Research


21ST CENTURY CURES DISCUSSION DRAFT TITLE I - DISCOVERY SUBTITLE A- NATIONAL INSTITUTES OF HEALTH FUNDING SECTION 1001 – NATIONAL INSTITUTES OF HEALTH REAUTHORIZATION This section would reauthorize the National Institu
Add to Reading List

Document Date: 2015-05-13 10:21:22

Open Document

File Size: 251,48 KB

Share Result on Facebook

Company

Commerce Bipartisan Telemedicine Member Working Group / CONTINUOUS DRUG MANUFACTURING / VITRO DIAGNOSTICS / NIH TRAVEL / BIOMEDICAL RESEARCH WORKING GROUP / IN CLINICAL TRIAL REGISTRY DATA BANK ON / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

biological products / health technology / health software / wireless platforms / information technology system / humanitarian device / pharmaceutical manufacturers / pharmaceutical / pediatric research network / health technologies / clinical protocols / pediatric clinical trial network / healthcare system / staff travel / drug development tools / susceptibility testing devices / combination product / certain breakthrough medical devices technologies / long-term solution / continuous manufacturing / /

MedicalCondition

rare diseases / rare pediatric disease priority review voucher / Multiple Sclerosis / birth defects / pediatric rare diseases / irreversibly debilitating diseases / rare disease / Parkinson’s disease / diseases / neurological diseases / /

MedicalTreatment

immunization / vaccination / clinical protocols / /

Organization

National Institute of Health / Defense Advanced Research Projects Agency / COUNCIL FOR 21ST CENTURY CURES SECTION / National Center for Advancing Translational Science / Medicare / Congress / federal government / office of the National / FDA / European Union / Reagan-Udall Foundation / Transaction Authority / /

Person

SILVIO O. CONTE / /

Position

physician / secretary / Governor / Coordinator / Director / /

Product

EXCLUSIVITY PERIODS FOR / FDA This / /

ProgrammingLanguage

NATURAL / C / /

Technology

health technology / medical devices technologies / Information Technology / SENSIBLE OVERSIGHT FOR TECHNOLOGY / IN VITRO DIAGNOSTICS / information technology system / clinical protocols / health technologies / smartphones / DRUG DEVELOPMENT / /

SocialTag